Icici Prudential Asset Management CO LTD Gilead Sciences, Inc. Transaction History
Icici Prudential Asset Management CO LTD
- $919 Million
- Q3 2025
A detailed history of Icici Prudential Asset Management CO LTD transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Icici Prudential Asset Management CO LTD holds 19,055 shares of GILD stock, worth $2.36 Million. This represents 0.23% of its overall portfolio holdings.
Number of Shares
19,055
Previous 15,589
22.23%
Holding current value
$2.36 Million
Previous $1.73 Million
22.4%
% of portfolio
0.23%
Previous 0.22%
Shares
20 transactions
Others Institutions Holding GILD
# of Institutions
2,367Shares Held
1.01BCall Options Held
8.58MPut Options Held
7.35M-
Black Rock Inc. New York, NY121MShares$15 Billion0.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA119MShares$14.8 Billion0.21% of portfolio
-
State Street Corp Boston, MA59.1MShares$7.33 Billion0.23% of portfolio
-
Capital World Investors Los Angeles, CA45.2MShares$5.61 Billion0.72% of portfolio
-
Dodge & Cox San Francisco, CA30.1MShares$3.74 Billion1.93% of portfolio
About GILEAD SCIENCES, INC.
- Ticker GILD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,253,369,984
- Market Cap $156B
- Description
- Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...